Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of New Markers (FXII and Videocapillaroscopy) in Type 3 Angioedema

NCT03917680 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT03917680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03917680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of New Markers (FXII and Videocapillaroscopy) in Type 3 Angioedema
Lead sponsor
Brugmann University Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 29, 2018
Completion date
October 8, 2019
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angio edema